RxDoctor Payments DataLook up a doctor →

Roy Bowden, DO

Internal Medicine · Charleston, WVNPI 1174594642

Payments from drug & device makers

$14,153in general payments, 2019–2025

Across 879 payments — averaging $16.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • AbbVie$2K
  • AstraZeneca$1K
  • Amgen$913
  • Lilly USA, LLC$809
  • Novartis$720
  • plus $6K from 45 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk228$2,613
AbbVie(2 entities)110$2,144
AstraZeneca64$1,250
Amgen(2 entities)63$913
Lilly USA, LLC52$809
Novartis43$720
Pfizer32$548
Merck27$496
Astellas Pharma US Inc17$399
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC21$320
GSK20$320
Boehringer Ingelheim18$313
Bayer18$311
Sanofi-aventis U.S. LLC19$303
Teva Pharmaceuticals USA, Inc.18$284
Amarin Pharma, Inc.13$217
Abbott12$213
Shield Therapeutics Inc5$184
Optinose US, Inc.10$172
Johnson & Johnson(2 entities)10$167
Dexcom, Inc.8$148
Biohaven Pharmaceuticals, Inc.8$148
Exact Sciences9$143
Sumitomo Pharma America, Inc.5$94
Phathom Pharmaceuticals, Inc.6$86
Eisai Inc.4$74
Tactile Systems Technology Inc1$66
Biohaven Pharmaceutical Holding Company Ltd.3$65
Arbor Pharmaceuticals, Inc.4$55
Otsuka America Pharmaceutical, Inc.3$52
Xeris Pharmaceuticals, Inc.2$44
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$41
Paratek Pharmaceuticals, Inc.2$38
Daiichi Sankyo Inc.2$31
Advanced Respiratory, Inc2$30
Esperion Therapeutics, Inc.2$30
Pacira Therapeutics, Inc.1$29
Axsome Therapeutics, Inc.1$26
Gilead2$25
Corcept Therapeutics1$24
Genentech USA, Inc.1$24
Redhill Biopharma Inc.1$23
Aimmune Therapeutics, Inc.1$23
Nestle Healthcare Nutrition Inc.1$22
Optos, Inc.1$22
Dermira, Inc.1$18
Boston Scientific1$17
Insulet Corporation1$15
Heartflow, Inc.1$14
Kowa Pharmaceuticals America, Inc.1$13
E.r. Squibb & Sons, L.L.C.1$13

How this compares

$14,153 in reported general payments places this provider in the 95th percentile of 573 internal medicine providers in West Virginia.

See all internal medicine providers in West Virginia →

Medicare billing

Part B allowed, 2024
$199,932
Medicare patients
476
Services billed
3,236

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Charleston

See the full list for West Virginia →

Where these figures come from

Is this you, or does something look wrong? →